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Moderate renal insufficiency and the risk of cardiovascular mor- Recent clinical guidelines have called for more evi-
tality: Results from the NHANES I. dence examining risk factors for cardiovascular disease
Background. Conflicting evidence exists concerning whether in patients with chronic renal insufficiency [1]. Renalrenal insufficiency is an independent risk factor for cardiovas-
insufficiency is common among older adults, and patientscular disease in the general population. The objective of this
with renal insufficiency have a higher prevalence of car-study was to determine whether moderate renal insufficiency
was associated with total and cardiovascular mortality, inde- diovascular disease. Traditional cardiovascular disease
pendent of traditional cardiovascular risk factors, in a commu- risk factors are prevalent in patients with renal insuffi-
nity sample representative of the U.S. general non-institution- ciency, as aging [2], diabetes [3] and hypertension [4]alized population.
are common causes of renal failure. Thus, the higherMethods. Participants in the U.S. First National Health and
Nutrition Examination Survey (NHANES I, 1974–1975) and prevalence of cardiovascular disease in patients with re-
NHANES I Epidemiologic Follow-up Study (NHEFS, 1992, nal insufficiency may relate entirely to a higher preva-
18 year follow-up) were evaluated. The primary analysis was lence of traditional cardiovascular risk factors. In pro-
limited to 2352 adults with complete data, and no baseline car-
spective cohort studies, if an independent associationdiovascular disease. A creatinine of 104 to 146mol/L in women,
between renal insufficiency and cardiovascular diseaseand 122 to 177 mol/L in men (approximate glomerular filtra-
tion rate of 30 to 60 mL/min/1.73 m2) was defined as moderate is observed, in such circumstances renal insufficiency
renal insufficiency. Supplementary analyses included partici- may simply be a marker of the duration or severity of
pants with marked renal impairment and baseline cardiovascu- traditional modifiable risk factors. In other words, renallar disease.
insufficiency may predict future cardiovascular diseaseResults. The unadjusted hazard ratio for moderate renal in-
by reflecting a higher degree of baseline atherosclerosissufficiency compared to preserved renal function was signifi-
cant for total mortality (hazard ratio 1.7; 95% confidence inter- and or preexisting cardiovascular disease. In such cir-
val 1.3 to 2.2), and for cardiovascular mortality (2.2; 1.5 to 3.1). cumstances the epidemiologic association between renal
After adjustment for traditional cardiovascular risk factors,
insufficiency and cardiovascular disease would be consid-there was no independent association between moderate renal
ered non-causal.insufficiency and total mortality (1.0; 0.8 to 1.4), or cardiovascu-
lar mortality (1.2; 0.8 to 1.8). These results were consistent in However, renal insufficiency might instead initiate and
supplementary analyses. accelerate the progression of cardiovascular disease, ei-
Conclusions. These results do not support moderate renal ther through traditional risk factors or through mecha-insufficiency as an independent risk factor for cardiovascular dis-
nisms unique to the condition. Blood pressure increasesease in the general population. The association between moder-
as glomerular filtration rate declines, and renal insuffi-ate renal insufficiency and cardiovascular disease, demonstrated
in other epidemiologic studies, appears to be due to co-occur- ciency is associated with dyslipidemia. Unique factors
rence of renal insufficiency with traditional cardiovascular risk suggested to predispose to atherosclerosis and cardiomy-
factors.
opathy include an elevated arterial calcium-phosphate
product [5], hyperhomocyst(e)inemia [6–8], anemia [9],
increased inflammation [10], increased thrombosis [11],
alterations in lipoprotein profile [12, 13], increased uric
acid [14], increased insulin resistance, and unrecognizedKey words: kidney failure, chronic renal insufficiency, uremia, cardio-
vascular diseases, mortality, cohort studies, risk, nutrition surveys. aspects of uremia. These conditions are influenced by
renal function, becoming more pronounced as glomeru-Received for publication August 28, 2001
lar filtration rate declines. In this context renal insuf-and in revised form November 9, 2001
Accepted for publication November 12, 2001 ficiency could be deemed atherogenic and cardiomyo-
pathic, and the association between renal insufficiency 2002 by the International Society of Nephrology
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and cardiovascular disease would be considered causal. been validated with inulin clearance [17]. Based on data
availability, a serum creatinine of 104 to 146 mol/L inThus, ascertainment and quantification of the indepen-
dent cardiovascular risk of renal insufficiency is useful women and 122 to 177 mol/L in men was used to define
moderate renal insufficiency, which approximated a glo-to suggest the extent by which renal insufficiency may
cause cardiovascular disease, specifically through pro- merular filtration rate of 30 to 60 mL/min/1.73 m2.
Cardiovascular risk factors. Diabetes was defined byposed unique risk factors.
The purpose of the present study was to determine if an answer of “yes” to the question, “Do you have any
reason to think that you may have diabetes, sometimesmoderate renal insufficiency was associated with total
mortality and cardiovascular mortality, independent of called sugar diabetes or sugar disease?” Current smoking
was defined as answering “yes” to both questions: “Didtraditional cardiovascular risk factors, in a sample repre-
sentative of the U.S. adult, general, non-institutionalized you ever smoke at least 100 cigarettes or more in your
lifetime?” and “Do you smoke now?” The mean bloodpopulation.
pressure was calculated as the average of three separate
readings, the first of which was taken in the sitting posi-
METHODS
tion at the beginning of the examination (sitting), and
Study design, setting and participants the latter two taken at the end (sitting, recumbent). A
diagnosis of hypertension was based on JNC VI criteriaThe first National Health and Nutrition Examination
Survey (NHANES I), sponsored by the National Center [18] as systolic blood pressure 140 mm Hg, diastolic
blood pressure 90 mm Hg, and/or the current use offor Health Statistics, was conducted on a nationwide,
stratified, multi-stage, area probability sample represen- antihypertensives. The analytic methods for cholesterol,
calcium, phosphate, hemoglobin and uric acid are re-tative of the U.S. civilian non-institutionalized popula-
tion. The data from this study are available in the public ported elsewhere [19]. Hypercholesterolemia was defined
as a serum total cholesterol 6.2 mmol/L (239 mg/dL)domain, and provided the opportunity for the indepen-
dent analyses reported here. The survey consisted of a [20]. A serum calcium-phosphate ion product (mmol/L)2
was calculated by multiplying the calcium and phosphate.standardized health interview, medical examination, and
a series of laboratory and clinical investigations. Low- Anemia was defined as serum hemoglobin 130 g/L in
men, and 120 g/L in women [21]. Albuminuria was de-income persons, the elderly and women of childbearing
age were oversampled. In 1974 to 1975, 3059 participants fined as the presence of 0.3 g/L of albumin by urinary
dipstick. Electrocardiograms (ECG) were recorded as sin-of the total NHANES I sample, aged 25 to 74, were se-
lected for a detailed examination that included serum gle channel data, and left ventricular hypertrophy was as-
sessed through a semi-automated procedure by the Dal-creatinine. This subsample constituted a distinct national
probability sample, and was followed until 1992 in the housie Novocode ECG program [22].
Total and cardiovascular mortality. Follow-up dataNHANES I Epidemiologic Follow-up Study (NHEFS).
Among the 3059 participants, reasons for stepwise ex- based on interviews, health care facility medical records,
and death certificates, were collected in four waves ofclusion for the primary analysis included: missing vital
status (N 123), missing serum creatinine (447), and par- follow-up: 1982 to 1984, 1986, 1987 and 1992 [23]. Death
certificate, proxy interview or both ascertained death. Inticipants with a serum creatinine greater than 146mol/L
in women or 177 mol/L in men (6). Participants were the former case, the underlying principal cause of death
was coded according to the International Classification ofalso excluded if they reported a baseline history of myo-
cardial infarction, stroke or congestive heart failure, or Diseases, Ninth Revision (ICD-9). Cardiovascular death
was defined by ICD-9 codes 390–459.demonstrated electrocardiogram evidence of myocardial
infarction (131) [15]. Compared to those participants
Data analysisincluded in the analysis, participants excluded from the
analysis were more likely to be older, smokers and dia- Data were analyzed using methodology that accounts
for the complex sampling design. Sample weights werebetic (data not shown). The remaining 2352 participants
were studied in the primary analysis. In supplementary used to account for oversampling and non-response. All
analyses were conducted with SUDAAN (Taylor series,analyses, inclusion criteria were extended to include par-
ticipants with higher serum creatinine and those with linearization method), a statistical program appropriate
for the analysis of complex sample survey data [24].baseline cardiovascular disease.
Baseline differences between the two groups on cardio-
Measurements vascular risk factors were tested with either weighted
independent samples t test, or weighted 2 method, and PSerum creatinine. Laboratory assessment of serum cre-
atinine was made by a non-kinetic alkaline picrate (Jaffe) values less than 0.05 were considered significant without
adjustment for multiple comparisons. Weighted Cox pro-method [16]. Participants were stratified into two groups
based on serum creatinine, using cut-points that have portional hazard regression models were used to exam-
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Table 1. Weighted distribution of characteristics stratified by serum creatinine cutpoints for each sex
SCr  122 in men SCr 122–177 in men
SCr  104 in women SCr 104–146 in women P value
Numberb 2132 220
Over 60 years of age 18 (1.0)% 34 (2.8)% 0.001
Women 53 (1.5)% 48 (4.1)% 0.20
Black race 9 (1.5)% 17 (4.7)% 0.15
Albuminuria 2 (0.5)% 2 (1.0)% 0.79
Diuretic use 10 (0.9)% 12 (2.8)% 0.28
Traditional cardiovascular risk factors
Diabetes mellitus history 4 (0.3)% 3 (0.4)% 0.74
Left ventricular hypertrophy ECG 6 (0.6)% 7 (1.7)% 0.88
Hypertensive 42 (1.8)% 52 (4.1)% 0.02
Systolic blood pressure mm Hg 130 (0.7) 135 (1.6) 0.001
Diastolic blood pressure mm Hg 83 (0.5) 86 (0.9) 0.001
Hypercholesterolemia 29 (1.2)% 43 (3.9)% 0.001
Total cholesterol mmol/L 5.66 (0.04) 6.08 (0.12) 0.001
Smoking history 40 (1.2)% 28 (2.2)% 0.001
Unique suggested cardiovascular risk factors
Anemia % 4 (0.8)% 4 (1.5)% 0.59
Hemoglobin
Men g/L 152 (0.6) 152 (1.0) 0.98
Women g/L 133 (1.0) 135 (1.4) 0.21
Calcium phosphate product mmol/L2 2.69 (0.01) 2.77 (0.04) 0.03
Uric acid lmol/L 328 (2.9) 394 (10.0) 0.001
Sample includes 2352 participants of the NHANES Ia, 1974–75. Abbreviations are: SCr, serum creatinine in mol/L; ECG, electrocardiogram. Proportions are
reported as a percentage (standard error), continuous variables as mean (standard error).
a NHANES I, First National Health and Nutrition Examination Survey
b Unweighted number of NHANES I participants
ine the relationship between renal insufficiency (as esti- deaths, and 197 unweighted cardiovascular deaths. The
mated by various methods) and total and cardiovascular overall crude total mortality rate and cardiovascular
mortality. Renal insufficiency was first examined in isola- mortality rate were 11.7 and 5.3 per 1000 person-years,
tion in the models, unadjusted for other risk factors. respectively. Participants with moderate renal insuffi-
Next, age (per year as a continuous variable) was entered ciency had higher crude rates for total mortality and
with renal insufficiency in the models. Finally, a total cardiovascular mortality compared to participants with
of six pre-defined traditional cardiovascular risk factors preserved renal function (total mortality 18.7 vs. 11.1,
were entered with renal insufficiency into the fully ad- cardiovascular mortality 10.4 vs. 4.8).
justed models: age (per year as a continuous variable), In Cox regression analyses, the unadjusted hazard ra-
sex (male/female), diabetes mellitus (yes/no), hypercho- tio for moderate renal insufficiency, compared to pre-
lesterolemia (yes/no), hypertension (yes/no) smoking served renal function, was significant for total mortality
(yes/no). Each analysis was conducted with complete [hazard ratio 1.7; 95% confidence interval (CI) was 1.3
information and methods of imputation were not used to 2.2] and cardiovascular mortality (HR 2.2; CI 1.5 to
to complete missing data. Missing individual item data 3.1). However, after adjusting for age, there was no inde-
ranged from 0 to 9% on baseline variables; 1.9% of data pendent association between moderate renal insuffi-
were missing for the primary adjusted Cox regression ciency and total mortality (HR 1.3; CI 0.9 to 1.7) or
model. cardiovascular mortality (HR 1.0; 0.8 to 1.4). Fully ad-
justed hazard ratios between risk factors and total and
cardiovascular mortality are presented in Table 2. Tradi-RESULTS
tional cardiovascular risk factors of male sex, older age,Differences in demographics and cardiovascular risk
hypercholesterolemia, hypertension, diabetes mellitusfactors between the two creatinine strata are shown in
and smoking were all independently associated with totalTable 1. Participants with moderate renal insufficiency
and cardiovascular mortality. After adjustment for tradi-compared to those with preserved renal function were
tional cardiovascular risk factors, the independent asso-more likely to be older, to have hypercholesterolemia and
ciation between moderate renal insufficiency and totalto be non-smokers. These participants were also more
mortality (HR 1.0; CI 0.8 to 1.4), or cardiovascular mor-likely to have higher systolic blood pressure, diastolic
tality (HR 1.2; CI 0.8–1.8) remained non-significant.blood pressure, calcium phosphate product and uric acid.
Several supplementary analyses were undertaken thatDuring an average of 16.1 years of follow-up (total
follow-up time, 18 years), there were 438 unweighted total confirmed the consistency of the results. First, other
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Table 2. Total and cardiovascular mortality for traditional risk rum creatinine greater than 146 mol/L in women or
factors and moderate renal insufficiency from Cox regression:
177 mol/L in men), and 131 participants with baselineNHANES I, 1974–1992
cardiovascular disease (total N  2489 participants).
Total mortality CVD mortality After adjustment for traditional cardiovascular risk fac-
Age (per year) 1.10 (1.09–1.11) 1.11 (1.10–1.12) tors, there was no independent association between mod-
Female 0.6 (0.5–0.8) 0.7 (0.5–1.0)
erate renal insufficiency and total mortality (HR 1.1;Diabetes mellitus 2.1 (1.3–3.5) 2.4 (1.4–4.2)
Hypercholesterolemia 1.3 (1.0–1.7) 1.6 (1.2–2.1) CI 0.9 to 1.4) or cardiovascular mortality (HR 1.4; CI 0.9
Hypertension 1.3 (1.0–1.6) 2.0 (1.4–2.8) to 1.9).
Smoking 2.4 (2.0–2.7) 2.9 (2.2–3.8)
Renal insufficiency
(SCr 122–177 in men, DISCUSSION104–146 in women) 1.0 (0.8–1.4) 1.2 (0.8–1.8)
These results demonstrate that moderate renal insuf-Weighted adjusted hazard ratios are reported as point estimates with 95%
confidence intervals. Of the 2352 participants in NHANES I (First National ficiency was not independently associated with total mor-
Health and Nutrition Examination Survey), 46 were not accounted for in the
tality or cardiovascular mortality in a community samplefully adjusted model because of missing information. Reference categories are
per year of age, male, and the absence of hypercholesterolemia, hypertension, representative of the U.S. non-institutionalized popula-
diabetes mellitus, smoking and a SCr 122 in men and 104 mol/L in women.
tion. In this study participants with moderate renal insuf-
ficiency were older, which explained the increased inci-
dence of total mortality and cardiovascular mortality in
individuals with moderate renal insufficiency.methods for entering serum creatinine in the fully ad-
In order to interpret these NHANES I findings in con-justed regression model were examined. There was no
text with the literature in a quantitative manner, English-independent association between serum creatinine (en-
language prospective cohort studies of 1000 participantstered as a continuous measure in mol/L) and total mor-
or more, which reported the independent associationtality (HR 1.00; CI 0.99 to 1.00; P 0.54), or cardiovascu-
between renal insufficiency and cardiovascular disease,lar mortality (HR 1.00; CI 1.00 to 1.01; P  0.35).
and were known to the authors as of April 2001, wereSimilarly, there was no independent association between
reviewed. These studies utilized different measurementslog transformed serum creatinine (entered as a continu-
of renal function and outcomes, and reporting biasesous measure in log mol/L) and total mortality (HR 0.8;
may have favored identification of positive results. ThisCI 0.6 to 1.3), or cardiovascular mortality (HR 1.5; 0.7
being recognized, these studies are presented in Tableto 3.2). Second, serum creatinine was categorized into
3, and quantitatively along with NHANES I results assex-specific quartiles in the fully adjusted model. There
graphs in Figures 1 and 2 [26–35]. In the presented litera-was no independent association between the quartiles
ture, the independent association between an elevatedand total mortality or cardiovascular mortality (data not
serum creatinine and cardiovascular disease is mostshown). Third, renal insufficiency was estimated by
prominent when there is co-occurrence of renal insuffi-Cockcroft-Gault creatinine clearance (in mL/min) in the
fully adjusted model [25]. There was no independent ciency with other traditional cardiovascular risk factors
such as pre-existing cardiovascular disease [29, 34, 35],association between creatinine clearance (entered as a
continuous measure) and total mortality (HR 1.00; CI hypertension [26, 30, 33], and older age [31, 32]. How-
ever, unlike other traditional cardiovascular risk factors,1.00 to 1.01; P  0.22), or cardiovascular mortality (HR
1.00; CI 0.99 to 1.02). Similarly, a Cockcroft-Gault creati- the independent association between renal insufficiency
and cardiovascular disease is either non-prominent [28]nine clearance between 30 and 60 mL/min compared to
a creatinine clearance greater than 60 mL/min was not or non-existent (Framingham [27] and NHANES I) in
the general population. The presented literature sup-independently associated with total mortality or cardio-
vascular mortality (data not shown). Fourth, unweighted ports the premise that renal insufficiency is a marker for
traditional cardiovascular risk factors not fully accountedadjusted Kaplan-Meier survival curves were plotted for
the two renal function groups for the primary sample for in statistical analysis, and that renal insufficiency per
se is not an independent risk factor for cardiovascular(data not shown). Over the 18-year follow-up, the lines
overlapped, confirming that an early short-term associa- disease. Renal insufficiency may be a marker for severity
of diabetes, hypertension or underlying atherosclerosis,tion between renal insufficiency and cardiovascular mor-
tality was not missed. Fifth, the fully adjusted regression a marker for misclassified diabetes or hypertension, a
marker for unrecognized cardiovascular risk factors suchmodel was examined in the subgroups of diabetes, hyper-
tension, older age and male sex. There was no indepen- as smoking or hypercholesterolemia, or a marker for
coexistent renal vascular disease, low cardiac output, ordent association between renal insufficiency and total
mortality or cardiovascular mortality in these subgroups. the use of cardiac medications such as diuretics. When
certain studies included participants with baseline car-Finally, the studied participants were broadened to in-
clude six participants with higher serum creatinine (a se- diovascular disease in their analyses, this obscured a
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Table 3. Prospective cohort studies from 1973 to 1999 quantifying the independent risk of renal insufficiency on
total mortality and cardiovascular outcomes
Ref. Setting and population Adjusted hazard ratio (95% CI)
Patients with hypertension
[26] Hypertension Detection and Follow-up Study (HDFP) Mortality
Cohort analysis in US Multicenter RCT, 1973–1982 SCr 150, 2.2 (1.9–2.5)
10,940 hypertensive participants, aged 30–69
Approximately 10% of participants had baseline CVD
Cholesterol not accounted for in analysis
[30] Progetto Ipertensione Umbria Monitoraggio Study (PIUMA) Mortalitya
3 Italian Medical Centers, 1988–1996 SCr 83 men and SCr 70 women (reference)
1829 hypertensive participants, approximate mean age 51 SCr 83–92 men and SCr 70–76 women, 1.0 (0.5–2.1)
All male participants had SCr 136, females SCr 120 mol/L SCr 92–103 men and SCr 76–84 women, 0.8 (0.4–1.8)
Excluded participants with baseline CVD SCr 103–136 men and SCr 84–120 women, 1.1 (0.6–2.2)
Cardiovascular event
SCr 83 men and SCr 70 women (reference)
SCr 83–92 men and SCr 70–76 women, 1.6 (1.0–2.5)
SCr 92–103 men and SCr 76–84 women, 1.6 (1.0–2.6)
SCr 103–136 men and SCr 84–120 women, 1.6 (1.0–2.5)
[33] Hypertension Optimal Treatment Study (HOT) Mortality
Cohort analysis in Multicenter RCT, 1992–1997 SCr 133–265, 2.9 (2.1–3.9)
18,790 hypertensive participants, aged 50 to 80 Cardiovascular mortality
All participants had SCr 265 SCr 133–265, 3.2 (2.1–4.9)
Approximately 8% of participants had baseline CVD Myocardial infarction
SCr 133–265, 1.4 (0.7–2.9)
Stroke
SCr 133–265, 1.6 (0.9–2.8)
Patients with established cardiovascular disease
[29] Studies of Left Ventricular Dysfunction (SOLVD) Mortality (Prevention Trial)
Cohort analysis in Multicenter RCT, 1986–1991 CCr 60, 1.4 (1.2–1.7)
Prevention Trial: 3673 asymptomatic participants Mortality (Treatment Trial)
Treatment Trial: 2161 symptomatic participants CCr 60, 1.4 (1.2–1.6)
Participants less than 80 years of age, mean age 61 Heart failure mortality (Prevention Trial)
Less than 1% of participants had SCr 177 CCr 60, 1.7 (1.2–2.4)
100% of participants had baseline CVD (LVEF 35%) Heart failure mortality (Treatment Trial)
Cholesterol and smoking not accounted for in analysis CCr 60, 1.5 (1.2–1.9)
[34] Heart Outcomes and Prevention Evaluation Study (HOPE) Cardiovascular event
Cohort analysis in Multicenter RCT, 1993–1999 SCr 124–200, 1.4 (1.2–1.7)
9287 participants, 55 years of age or older
All participants had SCr 200
80% of participants had baseline CVD
[35] Alberta Assessment of Heart Disease Study (APPROACH) Mortality
1 Canadian Province, 1995–1997 SCr 203, 2.5 (2.0–3.1)
16,793 participants not on dialysis undergoing angiography
Approximately 46% of participants were over 65 years of age
Greater than 60% of participants had baseline CVD
Older patients
[31, 32] Cardiovascular Health Study (CHS) Mortality
4 US communities, 1989–1996 SCr 80 (reference)
5201 participants, aged 64 SCr 80–97, 1.3 (1.0–1.7)
Approximately 25% of participants had baseline CVD SCr 97–106, 1.0 (0.7–1.4)
SCr 106–133, 1.4 (1.0–1.8)
SCr 133, 1.7 (1.3–2.3)
Stroke
SCr 80 (reference)
SCr 80–97, 1.3 (0.8–2.1)
SCr 97–106, 1.0 (0.8–1.7)
SCr 106–133, 1.4 (0.8–2.1)
SCr 133, 1.8 (1.1–2.9)
Patients in the general population
[27] Framingham Study (FRAMINGHAM) Mortality
1 US community, 1977–1994 Men SCr 136–265, 1.3 (1.0–1.7)
2837 men and 3386 women, aged 28–62 Women SCr 120–265, 1.1 (0.9–1.3)
All participants had SCr 265 Cardiovascular event
Approximately 14% of participants had baseline CVD Men SCr 136–265, 1.1 (0.8–1.4)
Women SCr 120–265, 1.0 (0.8–1.4)
(Continued)
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Table 3. (Continued)
Ref. Setting and population Adjusted hazard ratio (95% CI)
Patients in the general population
[28] British Regional Heart Study (BRHS) Mortality
24 UK communities, 1978–1993 SCr 116–129, 1.1 (0.9–1.3)
7690 men, aged 40–59 SCr 130, 1.4 (1.0–1.8)
Approximately 25% of participants had baseline CVD Cardiovascular mortality
Cholesterol not accounted for in analysis SCr 116–129, 1.1 (0.9–1.4)
SCr 130, 1.4 (1.0–2.1)
Ischemic heart event
SCr 130, 1.2 (0.8–1.7)
Stroke event
SCr 116, 1.6 (1.1–2.1)
Abbreviations are: CI, confidence interval; CVD, cardiovascular disease; SCr, serum creatinine (mol/L); CCr, creatinine clearance (mL/min); LVEF, left ventricular
ejection fraction; Ref., references; RCT, randomized controlled trial. Reference category for adjusted hazard ratios was preserved renal function.
a Unpublished data provided by study author
Fig. 1. Independent risk of renal insufficiency on total mortality, adjusted for traditional cardiovascular risk factors. Longitudinal studies are from
1973 to 1999. *Age adjusted rate; **unpublished data provided by the study author.
temporal relationship between renal insufficiency and patient population. If there is no independent association
between renal insufficiency and cardiovascular disease,the subsequent development of atherosclerosis and car-
diomyopathy. This may have contributed to an arti- then modifying potential unique risk factors that become
more pronounced with declining glomerular filtrationfactual independent association between renal insuffi-
ciency and cardiovascular disease. Thus, as concluded rate may not effective, unless such interventions are also
effective in patients with preserved renal function. Manyin the Framingham study [27], the association between
moderate renal insufficiency and cardiovascular disease clinical trials of emerging interventions in patients with re-
nal insufficiency are ongoing, and their results will guideappears to be due to co-occurrence of renal insufficiency
with other traditional cardiovascular risk factors. the truth of inferences made from observational longi-
tudinal data. With respect to established interventions,Chronic renal insufficiency is currently a non-modifi-
able entity. The primary reason of quantifying the inde- identifying renal insufficiency in the setting of pre-exist-
ing cardiovascular disease, hypertension or older age maypendent risk of renal insufficiency and cardiovascular
disease is to make inferences about the effectiveness of be clinically useful to emphasize the importance of using
established cardio-protective interventions. Comparedemerging and established interventions, that may be used
to reduce the burden of cardiovascular illness in this to patients with preserved renal function, patients with
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Fig. 2. Independent risk of renal insufficiency on cardiovascular events, adjusted for traditional cardiovascular risk factors. Longitudinal studies
are from 1973 to 1999. Comparing cardiovascular event rates was problematic because different cardiovascular outcomes are reported in the
studies. Here, cardiovascular events preferentially represented cardiovascular mortality or heart failure mortality when reported, or otherwise
represented myocardial infarction, stroke, or some composite of cardiovascular disease. *Age adjusted rate.
cardiovascular risk factors and renal insufficiency have nine in population studies is not an ideal measure of
chronic renal insufficiency. Single time point measure-a higher incidence of cardiovascular disease, and appear
to benefit equally (and in absolute terms possibly more) ments of serum creatinine may be subject to considerable
day-to-day variation and may not give as good an esti-from angiotensin-converting enzyme (ACE)-inhibitors
[34]. Post-hoc subgroup analyses of existing large clinical mate of renal function as a number of measurements. The
method used to assay serum creatinine in NHANES Itrials inclusive of subjects with renal insufficiency should
determine if this trend exists for other established cardio- (a non-kinetic alkaline picrate assay) may underestimate
glomerular filtration rate compared to methods used to-vascular interventions such as aspirin use, blood pressure
control, lipid lowering agents and endarterectomy in high day (such as a kinetic alkaline picrate assay). Unfortu-
nately it is impractical to use intravenous techniques ofgrade carotid stenosis.
This NHANES investigation contains many strengths. inulin and other markers to accurately assess renal func-
tion in large population cohorts, and no major studiesCareful standardized methods of data collection were
used, the results were consistent among different defini- have used 24-hour urinary creatinine clearance as the
method of assessment. The use of predictive equationstions of renal insufficiency, and the outcome was mortal-
ity. For the posed research question, it reports the longest for creatinine clearance and glomerular filtration rate
[26, 36] have limitations because ‘age,’ ‘sex,’ and ‘race’duration of follow-up of any study to date. It utilizes rep-
resentation of the heterogeneous U.S. population, sup- terms of an equation are known to be independent risk
factors for cardiovascular disease. In such circumstances,plementing findings from the Framingham cohort that
was almost exclusively Caucasian. It utilizes very specific any demonstrated association between predicted renal
insufficiency and cardiovascular disease may be con-(versus sensitive) definitions of important confounders
such as diabetes, which could bias the results toward founded by the included terms of the predictive equation.
Furthermore, this study cannot be used to estimate thefinding an independent association between renal insuf-
ficiency and cardiovascular disease. Recognizing these degree to which renal insufficiency contributes to cardio-
vascular disease by aggravating traditional cardiovascu-strengths, consideration should be given to limitations
of these NHANES data, which are also common to many lar disease risk factors such as hypertension, as this ag-
gravation may have occurred prior to cohort inception.observational studies. There may be important temporal
changes in medical assessment and therapy since this Factors such as hypertension also are included in fully
adjusted regression models, which prevents an estima-cohort’s inception 25 years ago. Ascertainment of cardio-
vascular disease occurred through the less than ideal tion of the degree to which renal insufficiency may cause
cardiovascular disease by aggravating hypertension (al-method of death certificates. An elevated serum creati-
Garg et al: Renal insufficiency and mortality 1493
5. Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calci-though in this study the association between moderate
fication in young adults with end-stage renal disease who are under-
renal insufficiency and cardiovascular mortality became going dialysis. N Engl J Med 342:1478–1483, 2000
6. Eikelboom JW, Lonn E, Genest J, et al: Homocyst(e)ine andnon-significant when the ‘age’ term alone was included
cardiovascular disease: a critical review of the epidemiologic evi-in the Cox regression model). Finally, like many other
dence. Ann Intern Med 131:363–375, 1999
studies, this NHANES study did not include any partici- 7. Wollesen F, Brattstrom L, Refsum H, et al: Plasma total homo-
cysteine and cysteine in relation to glomerular filtration rate inpants with an approximate glomerular filtration rate less
diabetes mellitus. Kidney Int 55:1028–1035, 1999than 30 mL/min/1.73 m2 or end-stage renal disease in the
8. Jungers P, Joly D, Massy Z, et al: Sustained reduction of hyperho-
primary analysis. Unique mechanisms for cardiovascu- mocysteinaemia with folic acid supplementation in predialysis pa-
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